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BACKGROUND 
Development of appropriate animal models that take growth and maturation into account is pivotal for pediatric preclinical pharmacokinetic research. 
To determine if the conventional pig (Landrace x Large White) is such a potential animal model, the ontogeny of the different elimination processes 
need to be unraveled. The kidneys play a pivotal role in the PK and PD of various drugs. The glomerular filtration rate (GFR) is considered as one of the 
most important estimators of the renal function. Over the last decade, iohexol has proven to be a sensitive and selective marker for GFR. Iohexol is a 
non-radiolabeled contrast medium, which is cleared solely by glomerular filtration. It has already been successfully applied in both human and 
veterinary medicine and seems to be of particular interest in the pediatric population as well. Since the renal function of adult pigs and humans display 
great similarities, the aim of this study was to determine the GFR in growing piglets using nonlinear mixed-effects modeling and correlate the data 
with the GFR data obtained in humans.  
METHODS 
RESULTS 
CONCLUSION ACKNOWLEDGMENTS 
Experimental protocol Population PK analysis 
64.7 mg/kg BW 
IV iohexol Blood 8 days (n=16) 
4 weeks  (n=8) 
7 weeks (n=16) 
6 months (n=8) catheter 
Analytical protocol 
Exo-iohexol 
HPLC-UV De Baere et al. (2012) 
Iohexol plasma concentration is best described using a 
two-compartmental model in pig, with BSA as 
covariate. The GFR values obtained in the current 
study were comparable to humans. Therefore, the pig 
could be a convenient juvenile animal model for 
studying the GFR in the pediatric subpopulation, and to 
evaluate the PK of renally excreted drugs.   
IV 
θCl = 74.89 mL/min/m²  
θQ = 12.38 L/h  
Central Compartment Peripheral Compartment 
Covariate effect of BSA (Cl = θCl*((BSA/mean BSA)1.45)*eη1) and (Vd = θ Vd *((BSA/mean BSA)
1.45)*eη2)  
1.11 
1.26 
1.45 
Nonlinear mixed-effects modeling was performed using 
Quasi Random Parametric Expectation Maximization 
(QRPEM) as an estimation method in Phoenix NLME®.  
- Structural model: two-compartmental with first order 
absorption and elimination.  
- Interindividual variability: exponential error model 
- Covariates tested: age, bodyweight, body surface area 
Model selection was based on the smaller values of -2LL, 
AIC and BIC, better precision of estimates, and superior 
goodness-of-fit plots 
θVc = 3.44 L  θVp = 3.51 L  
